Advertisement
Advertisement
CRIS
Curis Inc
0.88
USDSponsored
-0.07
-7.63%
Sep 24, 15:59 UTC -4
Closed
Pre-Market
0.91
+0.03
+2.92%
CRIS Earnings Reports
Positive Surprise Ratio
CRIS beat 22 of 38 last estimates.
58%
Next Report
Date of Next Report
Nov 04, 2026
Estimate for Q3 26 (Revenue/ EPS)
$765.00K
/-$5.24
Implied change from Q2 26 (Revenue/ EPS)
--
/+30.67%
Implied change from Q3 25 (Revenue/ EPS)
-75.91%
/-46.53%
Curis Inc earnings per share and revenue
On Aug 14, 2026, CRIS reported earnings of -4.01 USD per share (EPS) for Q2 26, beating the estimate of -7.99 USD, resulting in a 49.73% surprise. Revenue reached --, compared to an expected 1.02 million, with a -100.00% difference. The market reacted with a 0.00% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 4 analysts forecast an EPS of -5.24 USD, with revenue projected to reach 765.00 thousand USD, implying an increase of 30.67% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
AYTU BioPharma, Inc. Common Stock
Report Date
Sep 22, 2026 For Q4 26
Estimate
-$0.33
Actual
-$0.05
Surprise
+84.92%
Neuphoria Therapeutics Inc. Common Stock
Report Date
Sep 18, 2026 For Q4 26
Estimate
-$0.57
Actual
-$0.95
Surprise
-66.32%
NewcelX Ltd. Ordinary Shares
Report Date
Sep 18, 2026 For Q2 26
Estimate
-$0.54
Actual
-$0.96
Surprise
-77.58%
Abivax SA - ADR
Report Date
Sep 21, 2026 For Q2 26
Estimate
-$1.82
Actual
-$2.09
Surprise
-14.47%
AnaptysBio, Inc. Common Stock
Report Date
Sep 21, 2026 For Q2 26
Estimate
$0.00
Actual
$5.11
Surprise
>+10,000.00%
BlossomHill Therapeutics, Inc. Common Stock
Report Date
Sep 18, 2026 For Q2 26
Estimate
-$1.03
Actual
-$8.75
Surprise
-746.56%
Vogenx Inc Common Stock
Report Date
Sep 17, 2026 For Q2 26
Estimate
-$0.07
Actual
-$0.07
Surprise
+1.96%
Benitec Biopharma Inc. Common Stock
Report Date
Sep 14, 2026 For Q4 26
Estimate
-$0.27
Actual
-$0.26
Surprise
+5.59%
FAQ
What were Curis Inc's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Curis Inc reported EPS of -$4.01, beating estimates by 49.73%, and revenue of $0.00, -100% below expectations.
How did the market react to Curis Inc's Q2 2026 earnings?
The stock price moved -- 0%, changed from $1.80 before the earnings release to $1.80 the day after.
When is Curis Inc expected to report next?
The next earning report is scheduled for Nov 04, 2026.
What are the forecasts for Curis Inc's next earnings report?
Based on 4
analysts, Curis Inc is expected to report EPS of -$5.24 and revenue of $765.00K for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.